AMI Corporation Wins Startup Encouragement Award at 8th Japan Medical Research Development Award AMI Corporation, a pioneer in AI healthcare solutions, receives the Startup Encouragement Award at the 8th Japan Medical Research Development Award, marking a significant milestone in medical innovation.

AMI Corporation Wins Startup Encouragement Award at 8th Japan Medical Research Development Award #Japan #Kagoshima #AMI_Corporation #Cardio-EGG #Cloud超診

AMI Corporation Secures Regulatory Approval for DNP-AS Digital Biomarker Device AMI Corporation announces the approval of their DNP-AS digital biomarker device, aiming to revolutionize healthcare with innovative AI solutions.

AMI Corporation Secures Regulatory Approval for DNP-AS Digital Biomarker Device #Japan #Kagoshima #AMI_Corporation #DNP-AS #AI_Biomarkers

AMI Corporation Selected for NEDO Deep Tech Startup Support Program AMI Corporation has been chosen by NEDO for a support fund targeting deep tech startups, aiming to enhance healthcare accessibility through AI technology.

AMI Corporation Selected for NEDO Deep Tech Startup Support Program #Japan #NEDO #Kagoshima #AMI_Corporation #Deep_Tech_Startup

AMI Corporation Achieves Regulatory Approval for Digital Biomarker DNP-HF AMI Corporation has received regulatory approval for its digital biomarker, DNP-HF, enhancing remote medical services and innovation in healthcare.

AMI Corporation Achieves Regulatory Approval for Digital Biomarker DNP-HF #Japan #Kagoshima #AMI_Corporation #DNP-HF #Digital_Biomarker

AMI Corporation and MUSVI Form Strategic Partnership for Medical Innovation AMI Corporation and MUSVI have officially entered a strategic partnership aimed at revolutionizing remote medical services through innovative technology.

AMI Corporation and MUSVI Form Strategic Partnership for Medical Innovation #Japan #Kagoshima #MUSVI #Remote_Healthcare #AMI_Corporation

AMI Corporation Selected for Gunma Future Co-creation Trial Subsidy to Innovate Healthcare AMI Corporation has been chosen for the Gunma Future Co-creation Trial Subsidy to develop AI-powered telemedicine technology for early heart failure detection.

AMI Corporation Selected for Gunma Future Co-creation Trial Subsidy to Innovate Healthcare #Japan #Telemedicine #Kagoshima #Gunma_University #AMI_Corporation